Visualizing solvent mediated phase transformation behavior of carbamazepine polymorphs by principal component analysis

被引:9
作者
Tian, Fang [2 ]
Rades, Thomas [2 ]
Sandler, Niklas [1 ]
机构
[1] AstraZeneca R&D, Pharmaceut & Analyt R&D, Macclesfield SK10 2NA, Cheshire, England
[2] Univ Otago, Sch Pharm, Dunedin, New Zealand
关键词
carbamazepine; dihydrate; principal component analysis;
D O I
10.1208/s12249-008-9049-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this research is to gain a greater insight into the hydrate formation processes of different carbamazepine (CBZ) anhydrate forms in aqueous suspension, where principal component analysis (PCA) was applied for data analysis. The capability of PCA to visualize and to reveal simplified structures that often underlie large data sets are explored. Different CBZ polymorphs were dispersed separately in aqueous solution, and then recovered and measured by FT-Raman spectroscopy. PCA was employed for visualizing the dynamics of the phase transformation from each CBZ polymorph to the dihydrate (DH). As a comparison to PCA visualization, the transformation process of each CBZ polymorph was quantified using PLS modeling. The results demonstrated that PCA has advantages in presenting the original data in terms of the differences and similarities, and also directly identify the statistical patterns in the data even when the data set is large. These advantages provided greater insight into the measured Raman spectra as well as the phase transformation process of CBZ polymorphs to the DH in aqueous environment.
引用
收藏
页码:390 / 394
页数:5
相关论文
共 24 条
[1]   In situ measurement of solvent-mediated phase transformations during dissolution testing [J].
Aaltonen, Jaakko ;
Heinanen, Paula ;
Peltonen, Leena ;
Kortejarvi, Hanna ;
Tanninen, Veli Pekka ;
Christiansen, Leena ;
Hirvonen, Jouni ;
Yliruusi, Jouko ;
Rantanen, Jukka .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (12) :2730-2737
[2]  
[Anonymous], AM J HOSP PHARM
[3]  
[Anonymous], PLS TOOLBOX VERSION
[4]  
*FDA, 2004, GUID IND PAT FRAM IN, P21
[5]   Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I [J].
Grzesiak, AL ;
Lang, MD ;
Kim, K ;
Matzger, AJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (11) :2260-2271
[6]  
HARTLEY R, 1990, BRIT J CLIN PRACT, V44, P270
[7]   The potential of Raman spectroscopy as a process analytical technique during formulations of topical gels and emulsions [J].
Islam, MT ;
Rodríguez-Hornedo, N ;
Ciotti, S ;
Ackermann, C .
PHARMACEUTICAL RESEARCH, 2004, 21 (10) :1844-1851
[8]   Hydrate formation during wet granulation studied by spectroscopic methods and multivariate analysis [J].
Jorgensen, A ;
Rantanen, J ;
Karjalainen, M ;
Khriachtchev, L ;
Räsänen, E ;
Yliruusi, J .
PHARMACEUTICAL RESEARCH, 2002, 19 (09) :1285-1291
[9]  
KRAHN FU, 1987, PHARM ACTA HELV, V62, P247
[10]   FORMATION OF DIHYDRATE FROM CARBAMAZEPINE ANHYDRATE IN AQUEOUS CONDITIONS [J].
LAINE, E ;
TUOMINEN, V ;
ILVESSALO, P ;
KAHELA, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1984, 20 (03) :307-314